Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy

scientific article

Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/NXI.0000000000000001
P932PMC publication ID4202682
P698PubMed publication ID25340053

P50authorWinfried B. GraningerQ38639365
Franz FazekasQ43184302
Thomas GattringerQ47868316
Michael KhalilQ57021488
Alexander PichlerQ103833264
Christian EnzingerQ114270415
P2093author name stringJohannes Haybaeck
Petra Schwingenschuh
Christina Ernst
Alexander Moser
P2860cites workNatalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringQ28243804
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.Q30583907
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease SectionQ30613846
Risk of natalizumab-associated progressive multifocal leukoencephalopathyQ34275329
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob diseaseQ37381059
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and CanadaQ43218822
P433issue1
P921main subjectmultiple sclerosisQ8277
P304page(s)e1
P577publication date2014-04-24
P1433published inNeurology(R) neuroimmunology & neuroinflammationQ27725776
P1476titleUnusual deterioration in a patient with multiple sclerosis on natalizumab therapy
P478volume1

Reverse relations

Q34368573Gathering thundercites workP2860

Search more.